SeaCrest Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
5,475
+308
+6% +$13.8K 0.03% 480
2026
Q1
$249K Sell
5,167
-555
-10% -$25.9K 0.03% 526
2025
Q4
$277K Sell
5,722
-600
-9% -$29.7K 0.03% 484
2025
Q3
$309K Sell
6,322
-3,050
-33% -$147K 0.03% 456
2025
Q2
$453K Buy
+9,372
New +$479K 0.05% 345
2024
Q1
Sell
-6,925
Closed -$355K 653
2023
Q4
$355K Buy
6,925
+699
+11% +$34.2K 0.04% 405
2023
Q3
$334K Sell
6,226
-113
-2% -$6.03K 0.04% 425
2023
Q2
$342K Sell
6,339
-969
-13% -$52.1K 0.04% 430
2023
Q1
$398K Buy
7,308
+90
+1% +$4.38K 0.05% 390
2022
Q4
$350K Sell
7,218
-92
-1% -$4.04K 0.05% 415
2022
Q3
$278K Buy
7,310
+950
+15% +$42.3K 0.04% 454
2022
Q2
$318K Buy
6,360
+318
+5% +$16.9K 0.04% 450
2022
Q1
$310K Buy
6,042
+140
+2% +$7.23K 0.04% 495
2021
Q4
$296K Buy
5,902
+58
+1% +$2.87K 0.03% 519
2021
Q3
$282K Buy
5,844
+148
+3% +$7.53K 0.03% 508
2021
Q2
$300K Buy
5,696
+39
+0.7% +$2.04K 0.04% 499
2021
Q1
$280K Sell
5,657
-13,008
-70% -$625K 0.04% 503
2020
Q4
$907K Buy
18,665
+22
+0.1% +$1.08K 0.13% 172
2020
Q3
$935K Buy
18,643
+453
+2% +$23.3K 0.15% 149
2020
Q2
$929K Buy
18,190
+1,427
+9% +$69.4K 0.16% 137
2020
Q1
$733K Buy
16,763
+11,957
+249% +$572K 0.16% 146
2019
Q4
$241K Sell
4,806
-890
-16% -$41.7K 0.04% 454
2019
Q3
$264K Sell
5,696
-292
-5% -$12.6K 0.05% 421
2019
Q2
$259K Sell
5,988
-600
-9% -$25.5K 0.05% 407
2019
Q1
$292K Sell
6,588
-432
-6% -$18.5K 0.05% 369
2018
Q4
$305K Sell
7,020
-3
-0% -$132 0.06% 327
2018
Q3
$314K Hold
7,023
0.05% 376
2018
Q2
$281K Buy
7,023
+500
+8% +$19.7K 0.05% 386
2018
Q1
$261K Buy
6,523
+1,864
+40% +$77.6K 0.05% 401
2017
Q4
$200K Buy
+4,659
New +$215K 0.04% 492

Other funds holding SNY

SeaCrest Wealth Management's SNY Position: Q2 2026 in Review

SeaCrest Wealth Management increased its Sanofi (SNY) stake by 6% in Q2 2026, buying an estimated $13.8K and bringing the position to 5,475 shares worth $234K. The position accounts for 0.03% of the portfolio, ranked #480.

SeaCrest Wealth Management first reported a position in SNY in Q4 2017 and has held it in 30 quarters since. The position peaked at $935K in Q3 2020. 108 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • SeaCrest Wealth Management held 5,475 shares of Sanofi worth $234K as of Q2 2026.
  • SeaCrest Wealth Management bought 308 Sanofi shares in Q2 2026, an estimated $13.8K.
  • Sanofi made up 0.03% of SeaCrest Wealth Management's portfolio in Q2 2026, its #480 holding.
  • SeaCrest Wealth Management first reported a position in Sanofi in Q4 2017 and has held it in 30 quarters since.
  • SeaCrest Wealth Management's Sanofi position peaked at $935K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.